Novartis Working on Price Cut Proposals for US, CEO tells NZZ

Sept. 20, 2025, 10:30 AM UTC

Novartis AG is looking at ways to propose price cuts to US President Donald Trump by the end of the month, Chief Executive Officer Vas Narasimhan told Neue Zuercher Zeitung in an interview on Saturday.

“We’re working with the government to find constructive solutions so Americans pay less for their medicines,” Narasimhan said, adding that the company was also working to eliminate the price gap between the US and other industrialized countries.

In August, Trump asked drugmakers across the globe to lower what they charge Medicaid for existing drugs. He also asked them to guarantee future medicines be launched and ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.